Definitions of the phenotypic manifestations of sickle cell disease
SK Ballas, S Lieff, LJ Benjamin… - American journal of …, 2010 - Wiley Online Library
Sickle cell disease (SCD) is a pleiotropic genetic disorder of hemoglobin that has profound
multiorgan effects. The low prevalence of SCD (∼ 100,000/US) has limited progress in …
multiorgan effects. The low prevalence of SCD (∼ 100,000/US) has limited progress in …
[PDF][PDF] Definitions of the phenotypic manifestations of sickle cell disease.
SK Ballas, S Lieff, LJ Benjamin, CD Dampier… - core.ac.uk
Sickle cell disease (SCD) is a pleiotropic genetic disorder of hemoglobin that has profound
multi-organ effects. The low prevalence of SCD (~ 100,000/US) has limited progress in …
multi-organ effects. The low prevalence of SCD (~ 100,000/US) has limited progress in …
[PDF][PDF] Definitions of the phenotypic manifestations of sickle cell disease.
SK Ballas, S Lieff, LJ Benjamin, CD Dampier… - Citeseer
Sickle cell disease (SCD) is a pleiotropic genetic disorder of hemoglobin that has profound
multi-organ effects. The low prevalence of SCD (~ 100,000/US) has limited progress in …
multi-organ effects. The low prevalence of SCD (~ 100,000/US) has limited progress in …
[PDF][PDF] Definitions of the phenotypic manifestations of sickle cell disease
SK Ballas, S Lieff, LJ Benjamin, C Dampier… - Am J …, 2010 - open.library.emory.edu
Sickle cell disease (SCD) is a pleiotropic genetic disorder of hemoglobin that has profound
multiorgan effects. The low prevalence of SCD (~ 100,000/US) has limited progress in …
multiorgan effects. The low prevalence of SCD (~ 100,000/US) has limited progress in …
Definitions of the phenotypic manifestations of sickle cell disease.
SK Ballas, S Lieff, LJ Benjamin, CD Dampier… - 2010 - jdc.jefferson.edu
Sickle cell disease (SCD) is a pleiotropic genetic disorder of hemoglobin that has profound
multiorgan effects. The low prevalence of SCD (approximately 100,000/US) has limited …
multiorgan effects. The low prevalence of SCD (approximately 100,000/US) has limited …
Definitions of the phenotypic manifestations of sickle cell disease
SK Ballas, S Lieff, LJ Benjamin… - American …, 2010 - utsouthwestern.elsevierpure.com
Sickle cell disease (SCD) is a pleiotropic genetic disorder of hemoglobin that has profound
multiorgan effects. The low prevalence of SCD (∼ 100,000/US) has limited progress in …
multiorgan effects. The low prevalence of SCD (∼ 100,000/US) has limited progress in …
[HTML][HTML] Definitions of the Phenotypic Manifestations of Sickle Cell Disease
SK Ballas, S Lieff, LJ Benjamin… - American journal of …, 2010 - ncbi.nlm.nih.gov
Sickle cell disease (SCD) is a pleiotropic genetic disorder of hemoglobin that has profound
multi-organ effects. The low prevalence of SCD (~ 100,000/US) has limited progress in …
multi-organ effects. The low prevalence of SCD (~ 100,000/US) has limited progress in …
Definitions of the phenotypic manifestations of sickle cell disease
SK Ballas, S Lieff, LJ Benjamin… - American journal …, 2010 - pubmed.ncbi.nlm.nih.gov
Sickle cell disease (SCD) is a pleiotropic genetic disorder of hemoglobin that has profound
multiorgan effects. The low prevalence of SCD (approximately 100,000/US) has limited …
multiorgan effects. The low prevalence of SCD (approximately 100,000/US) has limited …
[PDF][PDF] Definitions of the phenotypic manifestations of sickle cell disease
SK Ballas, S Lieff, LJ Benjamin, C Dampier… - Am J …, 2010 - academia.edu
Sickle cell disease (SCD) is a pleiotropic genetic disorder of hemoglobin that has profound
multiorgan effects. The low prevalence of SCD (~ 100,000/US) has limited progress in …
multiorgan effects. The low prevalence of SCD (~ 100,000/US) has limited progress in …
Definitions of the phenotypic manifestations of sickle cell disease
SK Ballas, S Lieff, LJ Benjamin, CD Dampier… - American Journal of …, 2009 - infona.pl
Sickle cell disease (SCD) is a pleiotropic genetic disorder of hemoglobin that has profound
multiorgan effects. The low prevalence of SCD (∼ 100,000/US) has limited progress in …
multiorgan effects. The low prevalence of SCD (∼ 100,000/US) has limited progress in …